Casey Questions Valeant Execs on Dramatic Drug Price Increases
The Senate Special Committee on Aging held a hearing entitled “Valeant Pharmaceuticals’ Business Model: The Repercussions for Patients and the Health Care System.” Senator Casey questioned Valeant Execs on their drug price practices.